ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,933, issued on Nov. 25, was assigned to MOCHIDA PHARMACEUTICAL Co. LTD. (Tokyo).
"Crosslinked alginic acid structure" was invented by Shoji Furusako (Tokyo), Tomohiro Narumi (Tokyo) and Tsutomu Satoh (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a novel crosslinked alginic acid, a crosslinked alginic acid structure, etc., by performing a crosslinking reaction using alginic acid derivatives represented by formula (I) and formula (II). As a result, a novel crosslinked alginic acid, crosslinked alginic acid structure, etc., are provided."
The patent was filed on Sept. 24, 2020, under Application No. 17/763,071.
*For further infor...